Rapport Therapeutics Inc (RAPP) Stock Price, Quote & News

Company Profile

Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including periphe...

Industry: Biotechnology

Sector: Healthcare

Phone: 857 321 8020

Website: www.rapportrx.com

Address:

1325 Boylston Street, Suite 401, Boston, United States

HedgeAlerts Nov. 14 at 6:04 PM

Hedge Alert Live - Protect Your Portfolio Contract: $RAPP $25.00 Put · NOV 21, 2025 Exp Entry Price: $1.11 - $2.80 Exit Price Target: $2.11 Profit Margin: +90% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com

0 · Reply

LiquidThetaOptions Nov. 14 at 3:00 PM

💎 LiquidTheta® Live Actionable Trade Asset: $RAPP Contracts: $RAPP May 15, 2026 $25 Calls Scale in: $4.92- $6.02 Scale out: $19.14-$32.82 Profit Potential : 140% ROI Blended Join 💎 Here: https://liquidtheta.com

0 · Reply

HedgeAlerts Nov. 14 at 7:24 AM

Hedge Alert Live - Protect Your Portfolio Contract: $RAPP $22.50 Put · NOV 21, 2025 Exp Entry Price: $0.41 - $0.60 Exit Price Target: $0.57 Profit Margin: +40% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com

0 · Reply

LiquidThetaOptions Nov. 13 at 8:18 AM

💎 LiquidTheta® Live Actionable Trade Asset: $RAPP Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $4.09- $5.00 Scale out: $15.92-$27.30 Profit Potential : 145% ROI Blended Join 💎 Here: https://liquidtheta.com

0 · Reply

LiquidThetaOptions Nov. 12 at 10:40 AM

💎 LiquidTheta® Live Actionable Trade Asset: $RAPP Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $4.16- $5.09 Scale out: $16.19-$27.75 Profit Potential : 393% ROI Blended Join 💎 Here: https://liquidtheta.com

0 · Reply

LiquidThetaOptions Nov. 11 at 2:19 PM

💎 LiquidTheta® Live Actionable Trade Asset: $RAPP Contracts: $RAPP May 15, 2026 $25 Calls Scale in: $4.77- $5.82 Scale out: $18.53-$31.77 Profit Potential : 450% ROI Blended Join 💎 Here: https://liquidtheta.com

0 · Reply

LiquidThetaOptions Nov. 8 at 4:40 PM

💎 LiquidTheta® Live Actionable Trade Asset: $RAPP Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $5.36- $6.56 Scale out: $20.86-$35.76 Profit Potential : 297% ROI Blended Join 💎 Here: https://liquidtheta.com

0 · Reply

LiquidThetaOptions Nov. 7 at 2:44 PM

💎 LiquidTheta® Live Actionable Trade Asset: $RAPP Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $5.54- $6.78 Scale out: $21.56-$36.96 Profit Potential : 215% ROI Blended Join 💎 Here: https://liquidtheta.com

0 · Reply

JarvisFlow Nov. 7 at 2:16 PM

Citizens updates rating for Rapport Therapeutics ( $RAPP ) to Market Outperform, target set at 77 → 80.

0 · Reply

LiquidThetaOptions Nov. 6 at 10:46 AM

💎 LiquidTheta® Options Alert Asset: $RAPP Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $5.59- $6.83 Scale out: $21.73-$37.26 Profit Potential : 271% ROI Blended Join 💎 Here: https://liquidtheta.com

0 · Reply

Rapport Therapeutics Reports Third Quarter 2025 Financials and Provides Business Update

Nov 5, 2025, 4:05 PM EST - 9 days ago

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Nov 3, 2025, 9:58 AM EST - 11 days ago

Biotech is back. Here's why these rallying stocks belong in your portfolio now.

ABBV ALNY AMGN BMY LLY MBX MDGL

Oct 7, 2025, 9:03 AM EDT - 5 weeks ago

Rapport Acquires Aquifer Motion, Becoming the First Company to Offer Real-Time, AI-Powered Avatars with Full-Body Animation

Sep 17, 2025, 2:03 PM EDT - 2 months ago

Rapport Therapeutics, Inc. (RAPP) Presents at TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit Transcript

Sep 12, 2025, 5:11 AM EDT - 2 months ago

Crédit Agricole Normandie Seine : Rapport financier semestriel 06 2025

Sep 11, 2025, 4:05 PM EDT - 2 months ago

Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

Sep 10, 2025, 2:22 PM EDT - 2 months ago

Rapport stock plunges 18% on Wednesday: what went wrong after 200% rally

Sep 9, 2025, 9:17 PM EDT - 2 months ago

Rapport Announces Pricing of Public Offering of Common Stock

Sep 8, 2025, 4:05 PM EDT - 2 months ago

Rapport Announces Proposed Public Offering of Common Stock

Sep 8, 2025, 10:54 AM EDT - 2 months ago

Rapport stock rockets nearly 200% today, but analysts warn of possible crash soon

Sep 8, 2025, 6:00 AM EDT - 2 months ago

Rapport Announces Positive Topline Results from Phase 2a Clinical Trial of RAP-219 in Patients with Focal Onset Seizures

Sep 5, 2025, 4:05 PM EDT - 2 months ago

Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025

Aug 7, 2025, 7:00 AM EDT - 3 months ago

Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update

Jun 2, 2025, 2:45 PM EDT - 5 months ago

Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates

May 27, 2025, 7:00 AM EDT - 6 months ago

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare Conference

May 21, 2025, 7:00 AM EDT - 6 months ago

Rapport Therapeutics to Host 2025 Investor and Analyst Day

May 8, 2025, 7:00 AM EDT - 6 months ago

Rapport Therapeutics Reports First Quarter 2025 Financials and Provides Business Update

Apr 30, 2025, 11:45 AM EDT - 7 months ago

Mise à disposition du rapport financier annuel 2024

Apr 18, 2025, 7:46 AM EDT - 7 months ago

Meloni and Trump: An Oval Office Meeting With Rapport and Banter

Mar 27, 2025, 7:00 AM EDT - 8 months ago

Crédit Agricole Ille-et-Vilaine : Communiqué de mise à disposition du rapport financier 2024

Mar 21, 2025, 2:26 PM EDT - 8 months ago

Bpce: Mise à disposition du document d'enregistrement universel 2024 et du rapport financier annuel du Groupe BPCE

Mar 21, 2025, 7:00 AM EDT - 8 months ago

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting

Mar 13, 2025, 12:14 PM EDT - 8 months ago

Correction: Mise à disposition des éléments préparatoires à l'AG du 28/03/2025 - Rapport Financier Annuel 2024

Mar 13, 2025, 3:00 AM EDT - 8 months ago

Mise à disposition des éléments préparatoires à l'AG du 28/03/2025 - Rapport Financier Annuel 2024

Mar 11, 2025, 7:00 AM EDT - 8 months ago

Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 3, 2025, 7:00 AM EST - 9 months ago

Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development

Jan 9, 2025, 9:12 AM EST - 11 months ago

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

Jan 9, 2025, 7:00 AM EST - 11 months ago

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

Dec 6, 2024, 12:01 PM EST - 1 year ago

Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

Nov 14, 2024, 7:00 AM EST - 1 year ago

Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting

Nov 4, 2024, 7:00 AM EST - 1 year ago

Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November

Oct 18, 2024, 10:51 AM EDT - 1 year ago

This Rapport Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

COFS NEON PCT SELF

Sep 17, 2024, 2:35 AM EDT - 1 year ago

Rapport semestriel Pilier 3 - 30 juin 2024

Sep 5, 2024, 7:00 AM EDT - 1 year ago

Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences

Aug 29, 2024, 7:00 AM EDT - 1 year ago

Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen's 4th Annual Novel Mechanisms in Neuropsychiatry Summit

Jul 29, 2024, 7:00 AM EDT - 1 year ago

Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain

Jun 12, 2024, 4:01 PM EDT - 1 year ago

Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares and Concurrent Private Placement

Jun 7, 2024, 11:48 AM EDT - 1 year ago

J&J-backed Rapport Therapeutics valued at $636.8 mln after shares rise 6% in debut

JNJ

Jun 6, 2024, 7:57 PM EDT - 1 year ago

J&J-backed Rapport Therapeutics raises $136 mln in US IPO

JNJ

Jun 6, 2024, 6:54 PM EDT - 1 year ago

Rapport Therapeutics Announces Pricing of Initial Public Offering

Jun 3, 2024, 1:14 PM EDT - 1 year ago

J&J-backed Rapport Therapeutics seeks about $637 mln valuation in US IPO

JNJ

May 22, 2024, 4:17 PM EDT - 1 year ago

Rapport Therapeutics Seeks IPO For CNS Treatment Programs

HedgeAlerts Nov. 14 at 6:04 PM

0 · Reply

LiquidThetaOptions Nov. 14 at 3:00 PM

0 · Reply

HedgeAlerts Nov. 14 at 7:24 AM

0 · Reply

LiquidThetaOptions Nov. 13 at 8:18 AM

0 · Reply

LiquidThetaOptions Nov. 12 at 10:40 AM

0 · Reply

LiquidThetaOptions Nov. 11 at 2:19 PM

0 · Reply

LiquidThetaOptions Nov. 8 at 4:40 PM

0 · Reply

LiquidThetaOptions Nov. 7 at 2:44 PM

0 · Reply

JarvisFlow Nov. 7 at 2:16 PM

Citizens updates rating for Rapport Therapeutics ( $RAPP ) to Market Outperform, target set at 77 → 80.

0 · Reply

LiquidThetaOptions Nov. 6 at 10:46 AM

0 · Reply

LiquidThetaOptions Nov. 4 at 3:01 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $28.54 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $6.54- $8.00 Scale out: $10.18-$13.09 Can Easily Capture: 60% ROI Blended DTE: 193 Days | Join Elites here: https://liquidtheta.com

0 · Reply

LiquidThetaOptions Nov. 3 at 4:06 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $28.93 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $5.86- $7.16 Scale out: $9.11-$11.72 Can Easily Capture: 60% ROI Blended DTE: 194 Days | Join Elites here: https://liquidtheta.com

0 · Reply

LiquidThetaOptions Nov. 2 at 4:46 AM

0 · Reply

LiquidThetaOptions Nov. 1 at 2:28 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $28.31 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $5.61- $6.86 Scale out: $8.73-$11.22 Can Easily Capture: 60% ROI Blended DTE: 196 Days | Join Elites here: https://liquidtheta.com

0 · Reply

LiquidThetaOptions Oct. 31 at 12:37 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $26.88 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $5.36- $6.56 Scale out: $8.34-$10.73 Can Easily Capture: 60% ROI Blended DTE: 196 Days | Join Elites here: https://liquidtheta.com

0 · Reply

LiquidThetaOptions Oct. 30 at 1:37 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $28.68 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $6.54- $8.00 Scale out: $10.18-$13.09 Can Easily Capture: 60% ROI Blended DTE: 198 Days | Join Elites here: https://liquidtheta.com

0 · Reply

LiquidThetaOptions Oct. 28 at 1:43 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $26.21 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $6.54- $8.00 Scale out: $10.18-$13.09 Can Easily Capture: 60% ROI Blended DTE: 200 Days | Join Elites here: https://liquidtheta.com

0 · Reply

LiquidThetaOptions Oct. 26 at 6:48 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $25.93 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $5.81- $7.11 Scale out: $9.04-$11.63 Can Easily Capture: 60% ROI Blended DTE: 201 Days | Join Elites here: https://liquidtheta.com

0 · Reply

LiquidThetaOptions Oct. 25 at 9:07 PM

0 · Reply

LiquidThetaOptions Oct. 24 at 6:35 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $25.16 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $5.52- $6.75 Scale out: $8.59-$11.04 Can Easily Capture: 60% ROI Blended DTE: 204 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

BillionerOfKing Oct. 23 at 2:14 PM

$RAPP Current Stock Price: $25.06 Contracts to trade: $25 RAPP Nov 21 2025 Call Entry: $0.65 Exit: $1.09 ROI: 67% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

LiquidThetaOptions Oct. 23 at 9:18 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $24.90 Contracts: $RAPP May 15, 2026 $25 Calls Scale in: $5.65- $6.90 Scale out: $8.79-$11.30 Can Easily Capture: 60% ROI Blended DTE: 205 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

Market Cap	918.66M
Revenue (ttm)	0.00
Net Income (ttm)	-78.31M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	282,700
Avg Vol	968,974
Day's Range	N/A - N/A
Shares Out	36.50M
Stochastic %K	12%
Beta	1.64
Analysts	Strong Sell
Price Target	$52.14